10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares,…
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: ‘We Were Surprised By Reported Deaths’
Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.
The Analyst Verdict: Exelixis In The Eyes Of 5 Experts
Exelixis (NASDAQ:EXEL) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish…
What Analysts Are Saying About Exelixis Stock
In the preceding three months, 4 analysts have released ratings for Exelixis (NASDAQ:EXEL), presenting a wide array of…
Recap: Exelixis Q4 Earnings
Exelixis (NASDAQ:EXEL) reported its Q4 earnings results on Tuesday, February 6, 2024 at 04:05 PM. Here’s what investors…
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell
• BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Earnings Preview For Exelixis
Exelixis (NASDAQ:EXEL) is set to give its latest quarterly earnings report on Tuesday, 2024-02-06. Here’s what investors need…
Breaking Down Exelixis: 7 Analysts Share Their Views
Exelixis (NASDAQ:EXEL) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish…
Exelixis Announces Detailed Results Of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib In Combination With Atezolizumab In Metastatic Castration-Resistant Prostate Cancer Presented At ASCO GU 2024
– Cabozantinib in combination with atezolizumab reduced the risk of disease progression or death by 35% in patients with metastatic castration-resistant prostate cancer –– Findings to be presented during an oral